92 related articles for article (PubMed ID: 2416888)
1. Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminoma.
Grem JL; Trump DL
J Clin Oncol; 1986 Jan; 4(1):41-5. PubMed ID: 2416888
[TBL] [Abstract][Full Text] [Related]
2. [A case of advanced testicular seminoma--chemotherapy and serum marker].
Nakamura K; Hagiwara M; Aikawa A; Deguchi N; Tazaki H; Takeshita E; Ito S
Gan No Rinsho; 1983 Dec; 29(15):1779-82. PubMed ID: 6199531
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of disseminated seminoma.
Einhorn LH; Williams SD
Cancer Clin Trials; 1980; 3(4):307-13. PubMed ID: 6159120
[TBL] [Abstract][Full Text] [Related]
4. [A case of bilateral germ cell tumor of the testis].
Saito M; Kondo A; Kinjo T
Hinyokika Kiyo; 1989 Nov; 35(11):1961-4. PubMed ID: 2482675
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of extragonadal germ cell tumors.
Logothetis CJ; Samuels ML; Selig DE; Dexeus FH; Johnson DE; Swanson DA; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):316-25. PubMed ID: 2579212
[TBL] [Abstract][Full Text] [Related]
6. Reduced dose PVB treatment of stage IIC-IV testicular seminoma.
Berkmen F
Eur J Surg Oncol; 1993 Feb; 19(1):24-6. PubMed ID: 7679655
[TBL] [Abstract][Full Text] [Related]
7. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
Vogelzang NJ; Lange PH; Goldman A; Vessela RH; Fraley EE; Kennedy BJ
Cancer Res; 1982 Nov; 42(11):4855-61. PubMed ID: 6181870
[TBL] [Abstract][Full Text] [Related]
8. [An autopsy case revealing bilateral successive testicular germ cell tumors of different cell types].
Tsukamoto H; Atari E; Okudaira M; Uchida T; Kobayashi K; Ishibashi A; Koshiba K
Gan No Rinsho; 1988 Apr; 34(4):505-10. PubMed ID: 2451763
[TBL] [Abstract][Full Text] [Related]
9. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
de Wit R; Sylvester R; Tsitsa C; de Mulder PH; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Vermeylen K; Stoter G
Br J Cancer; 1997; 75(3):432-5. PubMed ID: 9020492
[TBL] [Abstract][Full Text] [Related]
10. High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy.
Pinkerton CR; Pritchard J; Spitz L
J Clin Oncol; 1986 Feb; 4(2):194-9. PubMed ID: 2418168
[TBL] [Abstract][Full Text] [Related]
11. The place of surgery in the treatment of seminomatous testicular tumors.
Smith RB
Prog Clin Biol Res; 1984; 153():111-9. PubMed ID: 6206504
[TBL] [Abstract][Full Text] [Related]
12. [Stage II non-seminoma cancer of the testis: combined treatment with surgery and chemotherapy].
Orlandi L; Van Cauwelaert R; Orlandi F; Vargas R; San MartÃn S; Arraztoa J
Actas Urol Esp; 1989; 13(1):53-5. PubMed ID: 2469300
[TBL] [Abstract][Full Text] [Related]
13. Therapy of a locally advanced testicular seminoma without metastases. A case report.
Abratt RP; Pontin AR; Sarembock LA
S Afr Med J; 1987 Aug; 72(3):212. PubMed ID: 2440118
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.
Levi JA; Thomson D; Sandeman T; Tattersall M; Raghavan D; Byrne M; Gill G; Harvey V; Burns I; Snyder R
J Clin Oncol; 1988 Jul; 6(7):1154-60. PubMed ID: 2455778
[TBL] [Abstract][Full Text] [Related]
15. VAB-6 chemotherapy causes spurious elevation of alpha-fetoprotein associated with liver dysfunctions.
Hida S; Nishimura K; Nishio Y; Oishi K; Takeuchi H; Yoshida O
Urol Int; 1991; 46(1):1-5. PubMed ID: 1708922
[TBL] [Abstract][Full Text] [Related]
16. [Primary intracranial malignant germ cell tumor associated with abnormal high value of alpha-fetoprotein and human chorionic gonadotropin].
Nishiyama K; Nishida K; Kusaka K; Morizumi H
No Shinkei Geka; 1987 Dec; 15(12):1337-42. PubMed ID: 2452372
[TBL] [Abstract][Full Text] [Related]
17. [False-positive elevation of alpha-fetoprotein during induction chemotherapy in patients with testicular cancer].
Hida S; Kawakita M; Oishi K; Okada Y; Takeuchi H; Okada K; Yoshida O
Hinyokika Kiyo; 1986 Dec; 32(12):1859-66. PubMed ID: 2435135
[TBL] [Abstract][Full Text] [Related]
18. [VAB-6 combination chemotherapy in patients with stage II, III testicular tumor].
Hida S; Kawakita M; Takenawa J; Fukuzawa S; Okuno H; Yamauchi T; Oishi K; Nishio Y; Takeuchi H; Okada K
Hinyokika Kiyo; 1986 Dec; 32(12):1849-58. PubMed ID: 2435134
[TBL] [Abstract][Full Text] [Related]
19. [Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy].
Riedinger JM; Eche N; Chevreau C; Fargeot P
Ann Biol Clin (Paris); 2008; 66(5):523-30. PubMed ID: 18957341
[TBL] [Abstract][Full Text] [Related]
20. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F
Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
